Amir Horowitz

7.9k total citations · 1 hit paper
66 papers, 3.5k citations indexed

About

Amir Horowitz is a scholar working on Immunology, Oncology and Surgery. According to data from OpenAlex, Amir Horowitz has authored 66 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Immunology, 14 papers in Oncology and 13 papers in Surgery. Recurrent topics in Amir Horowitz's work include Immune Cell Function and Interaction (40 papers), T-cell and B-cell Immunology (17 papers) and Bladder and Urothelial Cancer Treatments (11 papers). Amir Horowitz is often cited by papers focused on Immune Cell Function and Interaction (40 papers), T-cell and B-cell Immunology (17 papers) and Bladder and Urothelial Cancer Treatments (11 papers). Amir Horowitz collaborates with scholars based in United States, United Kingdom and Sweden. Amir Horowitz's co-authors include Michael A. Poles, Eleanor M. Riley, Saurabh Mehandru, Martin Markowitz, Daniel Boden, Klara Tenner‐Racz, Paul Rácz, Christine Hogan, Arlene Hurley and Peter Parham and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Nature Communications.

In The Last Decade

Amir Horowitz

61 papers receiving 3.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Primary HIV-1 Infection Is Associated with Preferential Depletion of CD4+ T Lymphocytes from Effector Sites in the Gastrointestinal Tract

2004 845 citations Saurabh Mehandru, Michael A. Poles et al. The Journal of Experimental Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Amir Horowitz United States	29	2.5k	938	616	595	571	66	3.5k
Constantinos Petrovas United States	30	2.3k 0.9×	1.4k 1.5×	580 0.9×	788 1.3×	611 1.1×	85	3.4k
Johan K. Sandberg Sweden	45	4.5k 1.8×	1.3k 1.4×	598 1.0×	1.4k 2.3×	800 1.4×	148	6.0k
Frédéric Baribaud United States	33	1.8k 0.7×	1.4k 1.5×	363 0.6×	1.0k 1.7×	1.2k 2.1×	67	4.2k
Vijayakumar Velu United States	29	1.8k 0.7×	979 1.0×	448 0.7×	993 1.7×	630 1.1×	96	3.0k
Jean Claude Gluckman France	23	2.2k 0.9×	1.1k 1.2×	335 0.5×	560 0.9×	781 1.4×	45	3.2k
Heribert Stoiber Austria	36	2.0k 0.8×	1.6k 1.7×	496 0.8×	921 1.5×	894 1.6×	119	3.6k
Jean‐Charles Grivel United States	39	1.9k 0.7×	1.8k 1.9×	462 0.8×	1.1k 1.9×	1.0k 1.8×	108	4.5k
Matthieu Perreau Switzerland	32	2.0k 0.8×	1.4k 1.5×	540 0.9×	1.1k 1.8×	1.4k 2.4×	71	3.8k
Rafael Cubas United States	24	2.4k 0.9×	850 0.9×	1.1k 1.9×	382 0.6×	349 0.6×	42	3.6k
Ronald L. Rabin United States	36	3.7k 1.5×	1.6k 1.7×	1.2k 2.0×	1.4k 2.4×	1.1k 1.9×	89	5.8k

Countries citing papers authored by Amir Horowitz

Since Specialization

Citations

This map shows the geographic impact of Amir Horowitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amir Horowitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amir Horowitz more than expected).

Fields of papers citing papers by Amir Horowitz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amir Horowitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amir Horowitz. The network helps show where Amir Horowitz may publish in the future.

Co-authorship network of co-authors of Amir Horowitz

This figure shows the co-authorship network connecting the top 25 collaborators of Amir Horowitz. A scholar is included among the top collaborators of Amir Horowitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amir Horowitz. Amir Horowitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Horowitz, Amir. (2024). Abstract IA007: Tumor HLA-E expression and cytomegalovirus infection modulate NK cell activity in human bladder cancer. Clinical Cancer Research. 30(10_Supplement). IA007–IA007. 2 indexed citations

Pfefferle, Aline, Jodie P. Goodridge, Ebba Sohlberg, et al.. (2024). Pan-cancer profiling of tumor-infiltrating natural killer cells through transcriptional reference mapping. Nature Immunology. 25(8). 1445–1459. 28 indexed citations

Dovey, Zach, Amir Horowitz, & Nikhil Waingankar. (2023). The influence of lifestyle changes (diet, exercise and stress reduction) on prostate cancer tumour biology and patient outcomes: A systematic review. SHILAP Revista de lepidopterología. 4(4). 385–416. 9 indexed citations

Huhn, Oisín, Veronika Karlsson, Delia Hawkes, et al.. (2023). Identification of Tissue-Resident Natural Killer and T Lymphocytes with Anti-Tumor Properties in Ascites of Ovarian Cancer Patients. Cancers. 15(13). 3362–3362. 11 indexed citations

Bashirova, Arman, Mathias Viard, Lee Garner, et al.. (2023). HLA class I signal peptide polymorphism determines the level of CD94/NKG2–HLA-E-mediated regulation of effector cell responses. Nature Immunology. 24(7). 1087–1097. 32 indexed citations

Ranti, Daniel, et al.. (2023). NK Cell-Targeted Immunotherapies in Bladder Cancer: Beyond Checkpoint Inhibitors. Bladder Cancer. 9(2). 125–139. 6 indexed citations

Ingersoll, Molly A., David C. Müller, Tahlita C.M. Zuiverloon, et al.. (2022). Biology of BCG response in non-muscle invasive bladder cancer - 2021 IBCN Updates Part III. Urologic Oncology Seminars and Original Investigations. 41(5). 211–218. 3 indexed citations

Strandgaard, Trine, Sia V. Lindskrog, Iver Nordentoft, et al.. (2022). Elevated T-cell Exhaustion and Urinary Tumor DNA Levels Are Associated with Bacillus Calmette-Guérin Failure in Patients with Non–muscle-invasive Bladder Cancer. European Urology. 82(6). 646–656. 39 indexed citations

Smith, Samantha, Philippa R Kennedy, Kevin Stacey, et al.. (2020). Diversity of peripheral blood human NK cells identified by single-cell RNA sequencing. Blood Advances. 4(7). 1388–1406. 112 indexed citations

10.

Sfakianos, John P., Bérengère Salomé, Jorge Daza, et al.. (2020). Bacillus Calmette-Guerin (BCG): Its fight against pathogens and cancer. Urologic Oncology Seminars and Original Investigations. 39(2). 121–129. 35 indexed citations

11.

Wang, Li, Yixuan Gong, Abdel Saci, et al.. (2019). Fibroblast Growth Factor Receptor 3 Alterations and Response to PD-1/PD-L1 Blockade in Patients with Metastatic Urothelial Cancer. European Urology. 76(5). 599–603. 89 indexed citations

12.

Laganà, Alessandro, Dan Fu Ruan, David T. Melnekoff, et al.. (2018). Increased HLA-E Expression Correlates with Early Relapse in Multiple Myeloma. Blood. 132(Supplement 1). 59–59. 3 indexed citations

13.

Hilton, Hugo G., Curtis McMurtrey, Zakia Djaoud, et al.. (2017). The Intergenic Recombinant HLA-B∗46:01 Has a Distinctive Peptidome that Includes KIR2DL3 Ligands. Cell Reports. 19(7). 1394–1405. 36 indexed citations

14.

Goyos, Ana, Lisbeth A. Guethlein, Amir Horowitz, et al.. (2015). A Distinctive Cytoplasmic Tail Contributes to Low Surface Expression and Intracellular Retention of the Patr-AL MHC Class I Molecule. The Journal of Immunology. 195(8). 3725–3736. 9 indexed citations

15.

Horowitz, Amir, Maryam Mehrabi, Emma L. Wise, et al.. (2011). A distinct subset of human NK cells expressing HLA‐DR expand in response to IL‐2 and can aid immune responses to BCG. European Journal of Immunology. 41(7). 1924–1933. 81 indexed citations

16.

Horowitz, Amir, et al.. (2010). Cross-Talk between T Cells and NK Cells Generates Rapid Effector Responses to Plasmodium falciparum - Infected Erythrocytes. The Journal of Immunology. 184(11). 6043–6052. 107 indexed citations

17.

Korbel, Daniel S., Paul J. Norman, Kirsty C. Newman, et al.. (2009). Killer Ig-Like Receptor ( KIR ) Genotype Predicts the Capacity of Human KIR-Positive CD56dim NK Cells to Respond to Pathogen-Associated Signals. The Journal of Immunology. 182(10). 6426–6434. 38 indexed citations

18.

Xing, Guo‐wen, Douglass Wu, Michael A. Poles, et al.. (2005). Synthesis and human NKT cell stimulating properties of 3-O-sulfo-α/β-galactosylceramides. Bioorganic & Medicinal Chemistry. 13(8). 2907–2916. 43 indexed citations

19.

Markowitz, Martin, Hiroshi Mohri, Saurabh Mehandru, et al.. (2005). Infection with multidrug resistant, dual-tropic HIV-1 and rapid progression to AIDS: a case report. The Lancet. 365(9464). 1031–1038. 114 indexed citations

20.

Mehandru, Saurabh, Michael A. Poles, Klara Tenner‐Racz, et al.. (2004). Primary HIV-1 Infection Is Associated with Preferential Depletion of CD4+ T Lymphocytes from Effector Sites in the Gastrointestinal Tract. The Journal of Experimental Medicine. 200(6). 761–770. 845 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact